• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Elektra Health and Oscar Launch HelloMeno the First-Ever Menopause Health Plan in the Individual Market

    10/20/25 8:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care
    Get the next $OSCR alert in real time by email

    NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Elektra Health ("Elektra"), a top virtual menopause care provider, and Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced a groundbreaking partnership offering the first-ever menopause health plan, HelloMeno, in the ACA marketplace.

    Oscar Health and Elektra Health

    "Menopause is an inevitable transition for midlife women with disruptive symptoms and long-term health consequences, yet the healthcare system has long ignored it," said Jannine Versi, CEO & Co-Founder, Elektra. "Our partnership with Oscar ensures that millions of women finally have affordable, comprehensive access to clinical care, education, and support that transforms health outcomes – and the decades that follow."

    HelloMeno is a bold new program empowering the 2.3 million women over 45 in the ACA to take control of perimenopause and menopause. The plan helps women age well at every step and save up to $9001 a year:

    • $0 primary doctor, gynecologist, and behavioral health visits.
    • No-cost labs, hormone replacement therapy, insomnia medications, and bone density scans.
    • 24/7 access to Elektra and a team of doctors who know menopause inside and out2 – specialists who actually listen, validate, and know the right next steps.
    • Low-cost treatments for autoimmune conditions like rheumatoid and psoriatic arthritis, Crohn's, and more.
    • Up to $120 in rewards for completing preventive care screenings, including mammograms and cancer screenings, and seeing a provider specializing in menopause.

    "HelloMeno is made for all of us," said Janet Liang, EVP, President of Oscar Insurance. "We offer real talk, trusted providers, and reliable resources. The plan is built by our team of clinicians who have gone through it – the 3 am wake-ups, brain fog, head-in-freezer moments, and everything in between. HelloMeno offers comprehensive coverage for the whole family, like all Oscar plans, but with benefits designed for women navigating the physical and emotional aspects of mid-life. We make more care affordable where it counts to help women everywhere, in every community, feel in control when life feels out of control."

    Women 45 and older represent a rapidly growing demographic with high healthcare costs. They often end up seeing multiple specialists or getting unnecessary tests to treat their symptoms – including going to the ER for symptoms like a racing heart. Oscar's HelloMeno with Elektra Health changes the game and goes beyond symptom management by prioritizing early intervention and proven high-value treatments for this phase of life. Women can map out a plan together with their primary care provider and Elektra's community of Menopause Society-certified clinicians. They access the right care – at costs they can afford – with additional community support, one-on-one coaching, and FDA-approved therapies without financial incentives for specific prescriptions.

    Women and their families can enroll in the plan during open enrollment from Nov. 1, 2025, through Jan. 15, 2026. HelloMeno, which goes into effect Jan. 1, 2026, will be available in Arizona, Florida,3 Georgia, Iowa, Missouri, Nebraska, North Carolina, Ohio, Oklahoma, Tennessee, and Texas.4

    For more information, visit hioscar.com/hellomeno.

    About Elektra Health

    Elektra is a virtual healthcare provider offering personalized medical care and support to empower the 50+ million midlife women in the U.S. navigating menopause. Its first-of-its-kind platform combines virtual care from board-certified clinicians with expertise from real coaches and educational resources created by Elektra MDs. In 2024, Elektra became the first (and remains the only) virtual menopause provider to accept both commercial and government-insured patients. Elektra is backed by leading investors (Equal Opportunity Ventures, UPMC Enterprises, Wavemaker 360, Flare Capital Partners, Catalyst by Wellstar, and Alexis Ohanian's 776 Fund). Together, we are on a mission to reimagine women's health as we age, starting with perimenopause.

    About Oscar Health

    Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 2.0 million members, as of June 30, 2025.

    Elektra Health Media Contact:

    Elena Riecke

    [email protected]

    (917) 485-1994

    Oscar Health Media Contact:

    Kristen Prestano

    VP of Communications

    [email protected]

    1 Savings based on an ACA plan with a CSR 150.

    2 In North Carolina, the virtual care provider partner for HelloMeno is Atrium Health.

    3 In Florida, Elektra Health is not available to members who have Oscar Health with AdventHealth HMO plans.

    4 Oscar Medical coverage is underwritten by Oscar Insurance Company and its affiliates. Administrative Services for all plans provided by Oscar Management Corporation. All insurance policies and group benefit plans contain exclusions and limitations.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elektra-health-and-oscar-launch-hellomeno-the-first-ever-menopause-health-plan-in-the-individual-market-302588091.html

    SOURCE Elektra Health

    Get the next $OSCR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OSCR

    DatePrice TargetRatingAnalyst
    10/14/2025$17.00Neutral
    Goldman
    7/25/2025$14.00Outperform → Neutral
    Robert W. Baird
    7/15/2025$11.00Neutral → Sell
    UBS
    7/14/2025$14.00Overweight → Neutral
    Piper Sandler
    7/11/2025$10.00Equal Weight → Underweight
    Wells Fargo
    7/2/2025$17.00Underweight
    Barclays
    6/24/2025Outperform → Mkt Perform
    Raymond James
    3/13/2025$20.00 → $16.00Overweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $OSCR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Elektra Health and Oscar Launch HelloMeno the First-Ever Menopause Health Plan in the Individual Market

    NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Elektra Health ("Elektra"), a top virtual menopause care provider, and Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced a groundbreaking partnership offering the first-ever menopause health plan, HelloMeno, in the ACA marketplace. "Menopause is an inevitable transition for midlife women with disruptive symptoms and long-term health consequences, yet the healthcare system has long ignored it," said Jannine Versi, CEO & Co-Founder, Elektra. "Our partnership with Oscar ensures that millions of wom

    10/20/25 8:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Unveils New Choices and AI Tools Shaping the Future of Individual Healthcare for More Americans and Businesses

    Oscar Health, Inc. (NYSE:OSCR), a leading healthcare technology company, is introducing a suite of easy-to-use health plans and AI features for millions of people for 2026 open enrollment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251020430145/en/The Oscar experience will be available in 573 counties in 20 states in 2026, including new expansions into Alabama and Mississippi. "Choice is power," said Mark Bertolini, CEO of Oscar Health. "Oscar's lineup of new products bring surprising new experiences and rewards to help members manage their health and get the most out of their plan. Everyone should be able to buy health cove

    10/20/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an

    10/8/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Oscar Health with a new price target

    Goldman initiated coverage of Oscar Health with a rating of Neutral and set a new price target of $17.00

    10/14/25 8:50:49 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Oscar Health from Outperform to Neutral and set a new price target of $14.00

    7/25/25 8:59:40 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health downgraded by UBS with a new price target

    UBS downgraded Oscar Health from Neutral to Sell and set a new price target of $11.00

    7/15/25 8:38:05 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Gassen William

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    10/14/25 4:36:51 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Plouffe David

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    10/14/25 4:36:19 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form 4 filed by Director Boyd Jeffery H

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    10/14/25 4:35:29 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Thrive Partners Vii Growth Gp, Llc bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/22/24 4:33:02 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Co-Founder and Vice Chairman Kushner Joshua bought $3,185,681 worth of shares (188,395 units at $16.91) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/22/24 4:29:47 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Director Thrive Partners Vii Growth Gp, Llc bought $5,444,343 worth of shares (344,522 units at $15.80) (SEC Form 4)

    4 - Oscar Health, Inc. (0001568651) (Issuer)

    11/18/24 5:02:12 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    SEC Filings

    View All

    Oscar Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities

    8-K - Oscar Health, Inc. (0001568651) (Filer)

    9/18/25 4:15:32 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Inc. filed SEC Form 8-K: Other Events

    8-K - Oscar Health, Inc. (0001568651) (Filer)

    9/16/25 6:10:07 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Inc. filed SEC Form 8-K: Other Events

    8-K - Oscar Health, Inc. (0001568651) (Filer)

    9/15/25 4:07:45 PM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Leadership Updates

    Live Leadership Updates

    View All

    Oscar Health, Inc. Announces Inducement Grants under Section 303A.08 of the NYSE Listed Company Manual

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar's Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar's common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly over a one-year period following their vesting commencement date, subject to continued employment. The awards were granted under Oscar's 2022 Employment Inducement Award Plan as employment inducement awards pursuant to the New York

    1/26/24 8:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built around a full stack technology platform, today announced the appointment of two seasoned healthcare executives to round out its leadership bench and further propel its vision to refactor healthcare. Kerry Sain has joined the company as the Executive Vice President of +Oscar, effective August 14, 2023, and Steven Kelmar will join as Executive Vice President and Chief of Staff to the CEO, effective September 21, 2023. In her role, Sain oversees the go-to-market strategy for the +Oscar business and will work closely with Mario Schlosser, President of Technology and Chief Technology Officer, to continue externa

    9/6/23 8:30:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health, Inc. Appoints Dr. Sean Martin, MD as New Chief Medical Officer

    Oscar Health, Inc. ("Oscar") (NYSE:OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr. Martin joined Oscar in 2016 and during his tenure has provided clinical leadership across a number of core clinical functions, including enterprise affordability, medical management, market performance, population health, and behavioral health. In his new role, he will be responsible for implementing Oscar's clinical capabilities and enhancing the quality of care and outcomes for its members. "Dr. Martin is an avid champion of the us

    3/15/23 8:30:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Financials

    Live finance-specific insights

    View All

    Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: 1.855.761.5600 Conference ID: 7768132 Webcast The call will be archived and available on Oscar's investor relations website (ir.hioscar.com) following November 6, 2025 for a period of 90 days. About Oscar Health Oscar Health, Inc. ("Oscar") is a leading healthcare technology company built around a full stack technology platform an

    10/8/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Announces Financial Results for Second Quarter 2025 and Reaffirms Updated 2025 Guidance

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR) announced today its financial results for the second quarter ended June 30, 2025, and reaffirmed its updated full year 2025 outlook across all metrics as provided in its preliminary financial results press release dated July 22, 2025. "We believe the individual market has long-term upside and is the future of healthcare," said Mark Bertolini, CEO of Oscar Health. "Oscar is well-positioned to manage through the market reset in 2025. We believe the market will stabilize next year, and expect to return to profitability in 2026. We are building the individual market into a healthcare marketplace for more consumers and businesses, and c

    8/6/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    Oscar Health Announces Preliminary Financial Results for Second Quarter 2025 and Revises 2025 Guidance

    Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR), a leading healthcare technology company, announced today certain preliminary financial results for the second quarter ended June 30, 2025 and updates to full year 2025 guidance. The Company expects a loss from operations of approximately $230 million and a net loss of approximately $228 million for the second quarter of 2025. The preannouncement is driven by a review of 2025 Marketplace data ("2Q Risk Adjustment Reports") from Wakely, an independent actuarial firm, that analyzes paid claims submissions through April 30, 2025 for most Marketplace insurance carriers. "The individual market is a competitive healthcare marketplace tha

    7/22/25 6:00:00 AM ET
    $OSCR
    Medical Specialities
    Health Care

    $OSCR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Oscar Health Inc.

    SC 13G/A - Oscar Health, Inc. (0001568651) (Subject)

    11/14/24 4:07:27 PM ET
    $OSCR
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Oscar Health Inc.

    SC 13G - Oscar Health, Inc. (0001568651) (Subject)

    11/14/24 1:28:35 PM ET
    $OSCR
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Oscar Health Inc.

    SC 13D/A - Oscar Health, Inc. (0001568651) (Subject)

    11/13/24 9:24:55 PM ET
    $OSCR
    Medical Specialities
    Health Care